Skip to main content
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
15.05
+1.67 (12.48%)
At close: Dec 5, 2025, 4:00 PM EST
15.16
+0.11 (0.73%)
After-hours: Dec 5, 2025, 7:52 PM EST

Kazia Therapeutics Revenue

In the fiscal year ending June 30, 2025, Kazia Therapeutics had annual revenue of 1.83M AUD, down -26.28%. Kazia Therapeutics had revenue of 1.81M in the half year ending June 30, 2025, with 180,571.00% growth.

Revenue (ttm)
1.83M AUD
Revenue Growth
-26.28%
P/S Ratio
13.75
Revenue / Employee
304,833 AUD
Employees
6
Market Cap
27.61M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20251.83M-652.00K-26.28%
Jun 30, 20242.48M2.48M248,000.00%
Jun 30, 20231,000.00-9.00K-90.00%
Jun 30, 202210.00K-15.17M-99.93%
Jun 30, 202115.18M14.19M1,436.54%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

KZIA News

More News